Copyright Reports & Markets. All rights reserved.

Global Prenatal Testing and Newborn Screening Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Prenatal Testing and Newborn Screening Service
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Prenatal Testing and Newborn Screening Service by Type
    • 1.3.1 Overview: Global Prenatal Testing and Newborn Screening Service Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Prenatal Testing and Newborn Screening Service Consumption Value Market Share by Type in 2022
    • 1.3.3 Intrusive
    • 1.3.4 Non-Invasive
  • 1.4 Global Prenatal Testing and Newborn Screening Service Market by Application
    • 1.4.1 Overview: Global Prenatal Testing and Newborn Screening Service Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Diagnostic Center
    • 1.4.4 Others
  • 1.5 Global Prenatal Testing and Newborn Screening Service Market Size & Forecast
  • 1.6 Global Prenatal Testing and Newborn Screening Service Market Size and Forecast by Region
    • 1.6.1 Global Prenatal Testing and Newborn Screening Service Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Prenatal Testing and Newborn Screening Service Market Size by Region, (2018-2029)
    • 1.6.3 North America Prenatal Testing and Newborn Screening Service Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Prenatal Testing and Newborn Screening Service Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Prenatal Testing and Newborn Screening Service Market Size and Prospect (2018-2029)
    • 1.6.6 South America Prenatal Testing and Newborn Screening Service Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Prenatal Testing and Newborn Screening Service Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 PerkinElmer
    • 2.1.1 PerkinElmer Details
    • 2.1.2 PerkinElmer Major Business
    • 2.1.3 PerkinElmer Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.1.4 PerkinElmer Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 PerkinElmer Recent Developments and Future Plans
  • 2.2 Natera
    • 2.2.1 Natera Details
    • 2.2.2 Natera Major Business
    • 2.2.3 Natera Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.2.4 Natera Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Natera Recent Developments and Future Plans
  • 2.3 Invitae
    • 2.3.1 Invitae Details
    • 2.3.2 Invitae Major Business
    • 2.3.3 Invitae Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.3.4 Invitae Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Invitae Recent Developments and Future Plans
  • 2.4 Centogene
    • 2.4.1 Centogene Details
    • 2.4.2 Centogene Major Business
    • 2.4.3 Centogene Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.4.4 Centogene Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Centogene Recent Developments and Future Plans
  • 2.5 Illumina
    • 2.5.1 Illumina Details
    • 2.5.2 Illumina Major Business
    • 2.5.3 Illumina Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.5.4 Illumina Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Illumina Recent Developments and Future Plans
  • 2.6 Natus Medical
    • 2.6.1 Natus Medical Details
    • 2.6.2 Natus Medical Major Business
    • 2.6.3 Natus Medical Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.6.4 Natus Medical Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Natus Medical Recent Developments and Future Plans
  • 2.7 Sequenom
    • 2.7.1 Sequenom Details
    • 2.7.2 Sequenom Major Business
    • 2.7.3 Sequenom Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.7.4 Sequenom Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Sequenom Recent Developments and Future Plans
  • 2.8 Cradle Genomics
    • 2.8.1 Cradle Genomics Details
    • 2.8.2 Cradle Genomics Major Business
    • 2.8.3 Cradle Genomics Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.8.4 Cradle Genomics Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Cradle Genomics Recent Developments and Future Plans
  • 2.9 Hoffmann-La Roche
    • 2.9.1 Hoffmann-La Roche Details
    • 2.9.2 Hoffmann-La Roche Major Business
    • 2.9.3 Hoffmann-La Roche Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.9.4 Hoffmann-La Roche Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Hoffmann-La Roche Recent Developments and Future Plans
  • 2.10 Quest Diagnostics
    • 2.10.1 Quest Diagnostics Details
    • 2.10.2 Quest Diagnostics Major Business
    • 2.10.3 Quest Diagnostics Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.10.4 Quest Diagnostics Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.11 Baebies
    • 2.11.1 Baebies Details
    • 2.11.2 Baebies Major Business
    • 2.11.3 Baebies Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.11.4 Baebies Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Baebies Recent Developments and Future Plans
  • 2.12 Ravgen
    • 2.12.1 Ravgen Details
    • 2.12.2 Ravgen Major Business
    • 2.12.3 Ravgen Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.12.4 Ravgen Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Ravgen Recent Developments and Future Plans
  • 2.13 Eurofins Scientific
    • 2.13.1 Eurofins Scientific Details
    • 2.13.2 Eurofins Scientific Major Business
    • 2.13.3 Eurofins Scientific Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.13.4 Eurofins Scientific Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Eurofins Scientific Recent Developments and Future Plans
  • 2.14 BGI Genomics
    • 2.14.1 BGI Genomics Details
    • 2.14.2 BGI Genomics Major Business
    • 2.14.3 BGI Genomics Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.14.4 BGI Genomics Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 BGI Genomics Recent Developments and Future Plans
  • 2.15 Shanghai Biotecan Pharmaceuticals Corporation
    • 2.15.1 Shanghai Biotecan Pharmaceuticals Corporation Details
    • 2.15.2 Shanghai Biotecan Pharmaceuticals Corporation Major Business
    • 2.15.3 Shanghai Biotecan Pharmaceuticals Corporation Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.15.4 Shanghai Biotecan Pharmaceuticals Corporation Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Shanghai Biotecan Pharmaceuticals Corporation Recent Developments and Future Plans
  • 2.16 Annaroad Gene
    • 2.16.1 Annaroad Gene Details
    • 2.16.2 Annaroad Gene Major Business
    • 2.16.3 Annaroad Gene Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.16.4 Annaroad Gene Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Annaroad Gene Recent Developments and Future Plans
  • 2.17 Guangzhou Darui Biotechnology
    • 2.17.1 Guangzhou Darui Biotechnology Details
    • 2.17.2 Guangzhou Darui Biotechnology Major Business
    • 2.17.3 Guangzhou Darui Biotechnology Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.17.4 Guangzhou Darui Biotechnology Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Guangzhou Darui Biotechnology Recent Developments and Future Plans
  • 2.18 Beijing Berry Genomics
    • 2.18.1 Beijing Berry Genomics Details
    • 2.18.2 Beijing Berry Genomics Major Business
    • 2.18.3 Beijing Berry Genomics Prenatal Testing and Newborn Screening Service Product and Solutions
    • 2.18.4 Beijing Berry Genomics Prenatal Testing and Newborn Screening Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Beijing Berry Genomics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Prenatal Testing and Newborn Screening Service Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Prenatal Testing and Newborn Screening Service by Company Revenue
    • 3.2.2 Top 3 Prenatal Testing and Newborn Screening Service Players Market Share in 2022
    • 3.2.3 Top 6 Prenatal Testing and Newborn Screening Service Players Market Share in 2022
  • 3.3 Prenatal Testing and Newborn Screening Service Market: Overall Company Footprint Analysis
    • 3.3.1 Prenatal Testing and Newborn Screening Service Market: Region Footprint
    • 3.3.2 Prenatal Testing and Newborn Screening Service Market: Company Product Type Footprint
    • 3.3.3 Prenatal Testing and Newborn Screening Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Prenatal Testing and Newborn Screening Service Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Prenatal Testing and Newborn Screening Service Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Prenatal Testing and Newborn Screening Service Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Prenatal Testing and Newborn Screening Service Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Prenatal Testing and Newborn Screening Service Consumption Value by Type (2018-2029)
  • 6.2 North America Prenatal Testing and Newborn Screening Service Consumption Value by Application (2018-2029)
  • 6.3 North America Prenatal Testing and Newborn Screening Service Market Size by Country
    • 6.3.1 North America Prenatal Testing and Newborn Screening Service Consumption Value by Country (2018-2029)
    • 6.3.2 United States Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Prenatal Testing and Newborn Screening Service Consumption Value by Type (2018-2029)
  • 7.2 Europe Prenatal Testing and Newborn Screening Service Consumption Value by Application (2018-2029)
  • 7.3 Europe Prenatal Testing and Newborn Screening Service Market Size by Country
    • 7.3.1 Europe Prenatal Testing and Newborn Screening Service Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)
    • 7.3.3 France Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Prenatal Testing and Newborn Screening Service Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Prenatal Testing and Newborn Screening Service Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Prenatal Testing and Newborn Screening Service Market Size by Region
    • 8.3.1 Asia-Pacific Prenatal Testing and Newborn Screening Service Consumption Value by Region (2018-2029)
    • 8.3.2 China Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)
    • 8.3.5 India Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Prenatal Testing and Newborn Screening Service Consumption Value by Type (2018-2029)
  • 9.2 South America Prenatal Testing and Newborn Screening Service Consumption Value by Application (2018-2029)
  • 9.3 South America Prenatal Testing and Newborn Screening Service Market Size by Country
    • 9.3.1 South America Prenatal Testing and Newborn Screening Service Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Prenatal Testing and Newborn Screening Service Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Prenatal Testing and Newborn Screening Service Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Prenatal Testing and Newborn Screening Service Market Size by Country
    • 10.3.1 Middle East & Africa Prenatal Testing and Newborn Screening Service Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Prenatal Testing and Newborn Screening Service Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Prenatal Testing and Newborn Screening Service Market Drivers
  • 11.2 Prenatal Testing and Newborn Screening Service Market Restraints
  • 11.3 Prenatal Testing and Newborn Screening Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Prenatal Testing and Newborn Screening Service Industry Chain
  • 12.2 Prenatal Testing and Newborn Screening Service Upstream Analysis
  • 12.3 Prenatal Testing and Newborn Screening Service Midstream Analysis
  • 12.4 Prenatal Testing and Newborn Screening Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Prenatal Testing and Newborn Screening Service market size was valued at USD 5642.1 million in 2022 and is forecast to a readjusted size of USD 13600 million by 2029 with a CAGR of 13.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Rapidly growing global population, rising adoption rate of obstetric testing equipment in clinics, rapid development of modern healthcare, and continuous regulation across the healthcare industry are the key factors driving the growth of prenatal testing and newborn screening services market revenue.
    Prenatal testing and newborn screening are effective methods for early detection of genetic metabolic diseases.
    This report is a detailed and comprehensive analysis for global Prenatal Testing and Newborn Screening Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Prenatal Testing and Newborn Screening Service market size and forecasts, in consumption value ($ Million), 2018-2029
    Global Prenatal Testing and Newborn Screening Service market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
    Global Prenatal Testing and Newborn Screening Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
    Global Prenatal Testing and Newborn Screening Service market shares of main players, in revenue ($ Million), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Prenatal Testing and Newborn Screening Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Prenatal Testing and Newborn Screening Service market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PerkinElmer, Natera, Invitae, Centogene and Illumina, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market segmentation
    Prenatal Testing and Newborn Screening Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Intrusive
    Non-Invasive
    Market segment by Application
    Hospital
    Diagnostic Center
    Others
    Market segment by players, this report covers
    PerkinElmer
    Natera
    Invitae
    Centogene
    Illumina
    Natus Medical
    Sequenom
    Cradle Genomics
    Hoffmann-La Roche
    Quest Diagnostics
    Baebies
    Ravgen
    Eurofins Scientific
    BGI Genomics
    Shanghai Biotecan Pharmaceuticals Corporation
    Annaroad Gene
    Guangzhou Darui Biotechnology
    Beijing Berry Genomics
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Prenatal Testing and Newborn Screening Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Prenatal Testing and Newborn Screening Service, with revenue, gross margin and global market share of Prenatal Testing and Newborn Screening Service from 2018 to 2023.
    Chapter 3, the Prenatal Testing and Newborn Screening Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Prenatal Testing and Newborn Screening Service market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
    Chapter 12, the key raw materials and key suppliers, and industry chain of Prenatal Testing and Newborn Screening Service.
    Chapter 13, to describe Prenatal Testing and Newborn Screening Service research findings and conclusion.

    Buy now